<DOC>
	<DOCNO>NCT00004909</DOCNO>
	<brief_summary>RATIONALE : Quality-of-life assessment patient undergoing cancer treatment may help determine intermediate- long-term effect treatment patient . PURPOSE : This clinical trial study effect chemotherapy give mouth versus chemotherapy give infusion quality life patient recurrent ovarian epithelial cancer .</brief_summary>
	<brief_title>Effect Chemotherapy Given Either Mouth Infusion Quality Life Patients With Recurrent Ovarian Epithelial Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine impact oral versus parenteral chemotherapy quality life ( QOL ) patient recurrent ovarian epithelial cancer . II . Evaluate QOL time patient population . III . Determine impact disease symptom , treatment side effect , performance status , CA-125 level QOL assessment patient population . OUTLINE : Patients receive baseline quality life ( QOL ) assessment , attitudes/preference survey , performance status assessment time diagnosis recurrent disease . Patients nonrandomly assign treatment either IV oral chemotherapy use drug base National Comprehensive Cancer Network guideline , prior treatment history , patient preference . QOL performance status assessment obtain 3 6 month treatment . Attitudes/preferences assess 6 month . Patients withdraw study treatment regimen change oral IV , IV oral 6 month . PROJECTED ACCRUAL : A total 74 patient accrue study 12 month .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose recurrent ovarian epithelial cancer recurrent primary peritoneal cancer evidence new clinical radiologic detect mass rise serum CA125 level No progressive disease ongoing treatment PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Fluent English Not pregnant nursing PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>peritoneal cavity cancer</keyword>
	<keyword>quality life</keyword>
</DOC>